Synthesis of characteristic lipopeptides of the human N-Ras protein and their 
evaluation as possible inhibitors of protein farnesyl transferase

Stober, P; Schelhaas, M; Nagele, E; Hagenbuch, P; Retey, J; Waldmann, Herbert

doi:10.1016/S0968-0896(96)00213-1

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Synthesis of characteristic lipopeptides of the human N-Ras protein and their evaluation as possible inhibitors of protein farnesyl transferase

MPS-Authors

/persons/resource/persons98735

Waldmann, Herbert
Abt. IV: Chemische Biologie, Max Planck Institute of Molecular Physiology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Stober, P., Schelhaas, M., Nagele, E., Hagenbuch, P., Retey, J., & Waldmann, H. (1997). Synthesis of characteristic lipopeptides of the human N-Ras protein and their evaluation as possible inhibitors of protein farnesyl transferase. BIOORGANIC & MEDICINAL CHEMISTRY, 5(1), 75-83. doi:10.1016/S0968-0896(96)00213-1.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0014-71E9-0

Abstract

Lipopeptides carrying a farnesyl thioether or a palmitic acid thioester and a farnesyl thioether were prepared from S-farnesyl cysteine methyl ester by N-terminal extension of the peptide chain employing the base labile Fmoc blocking group or the palladium(0) sensitive Aloc urethane. By means of this technique a lipohexapeptide representing the completely functionalized, i.e. palmitoylated and farnesylated C-terminus of the human N-Ras protein, was prepared. If acid labile blocking functions like the Boc group were used, upon deprotection an undesired addition of the acid to the double bonds of the farnesyl residue occurred. Therefore, acid labile blocking groups should not be employed in the synthesis of farnesylated lipopeptides. The lipopeptide methyl esters which carry only a farnesyl group do not inhibit protein farnesyl transferase, whereas palmitoylated peptides are weak inhibitors of this enzyme. Copyright (C) 1997 Elsevier Science Ltd.